Clinuvel Pharmaceuticals
CUV.AX
#6925
Rank
$0.43 B
Marketcap
$8.59
Share price
-1.79%
Change (1 day)
-19.40%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.41

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.41. In 2023 the company made an earnings per share (EPS) of $0.41 an increase over its 2022 EPS that were of $0.29.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.4140.79%
2022$0.29-22.53%
2021$0.3861.74%
2020$0.23-12.03%
2019$0.2628.75%
2018$0.2179.08%
2017$0.11-318.99%
2016-$0.05229-71.6%
2015-$0.1836.75%
2014-$0.13-23.66%
2013-$0.18-45.84%
2012-$0.33-18.99%
2011-$0.4025.76%
2010-$0.32-22.24%
2009-$0.41-10.59%
2008-$0.4646.78%
2007-$0.31-34.2%
2006-$0.48-25.89%
2005-$0.6440.91%
2004-$0.4655.12%
2003-$0.2952.02%
2002-$0.1971.69%
2001-$0.11355.46%
2000-$0.02472